$41.200
-2.464 (-5.98%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
IMVT Prediction & Forecast by Similar Chart Analysis
Alphio's IMVT stock price prediction model matches the current Immunovant Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $42.06 (+2.08%). The 1-week path is $42.94 (+4.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Immunovant Inc Stock?
Immunovant Inc is a good buy right now due to its recent positive clinical trial results showing a 72.7% improvement rate in patients, which significantly boosts its growth potential. The stock is currently priced at $41.20, well below the analyst price target of $50 from JPMorgan, indicating a substantial upside. However, investors should be cautious of the company's ongoing high net losses, which reached $147.9 million in the last quarter, representing a risk to short-term performance.
IMVT stock price ended at $41.20 on Friday, after losing -5.98%
Immunovant Inc (IMVT) last closed at $41.2, losing -5.98%. These facts feed the 1-day and 1-week IMVT price prediction above.
Forecast Drivers
Immunovant Inc (IMVT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches IMVT, ranked by similarity.
Seasonality analysis for IMVT
Historically the probability of a positive August return for IMVT is 31.75%. January offers the highest probability of a positive month at 37.70%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for IMVT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $20.74 | $21.53 | $22.42 | -47.74% |
| Sep 2026 | $19.49 | $21.63 | $24.77 | -47.51% |
| Oct 2026 | $11.99 | $15.98 | $17.74 | -61.20% |
| Nov 2026 | $12.10 | $15.98 | $17.52 | -61.20% |
| Dec 2026 | $11.48 | $15.98 | $16.79 | -61.20% |
In 2026, Immunovant Inc (IMVT) is projected to range from $11.48 to $24.77.
Immunovant Inc 2026 monthly forecast
In Aug 2026, Immunovant Inc is projected to average $21.53, with a low of $20.74 and high of $22.42.
In Sep 2026, Immunovant Inc is projected to average $21.63, with a low of $19.49 and high of $24.77.
In Oct 2026, Immunovant Inc is projected to average $15.98, with a low of $11.99 and high of $17.74.
In Nov 2026, Immunovant Inc is projected to average $15.98, with a low of $12.10 and high of $17.52.
In Dec 2026, Immunovant Inc is projected to average $15.98, with a low of $11.48 and high of $16.79.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.